Rayca Precision的封面图片
Rayca Precision

Rayca Precision

生物技术研究

San Francisco，CA 12,945 位关注者

Each discovery feeds the next.

关注

关于我们

Rayca’s AI rapidly designs, screens and optimizes thousands of therapeutic candidates for hard-to-drug targets, leading our owned and partnered therapeutic pipelines from concept to IND-approval. Rayca's platform is a closed-loop process where each data point—from screening, in vitro testing, or preclinical validation—feeds back into the AI models to continuously improve future drug designs. At Rayca Precision, we decode the complexity of disease biology using advanced multi-omics analysis powered by a secured, integrated bioinformatics platform, in silico virtual screenings, and predictive modeling to accelerate drug discovery. Our platform integrates potency matrices, dynamic molecular simulations, and high-resolution structural modeling to design highly optimized drug candidates. We specialize in creating a diverse range of therapeutic modalities, including small molecules, cyclic and linear peptides, peptidomimetics, bispecific antibodies, and RNA-based drugs. Leveraging best in class algorithms, we perform large-scale virtual screenings across uncharted chemical and biomolecular spaces to uncover cryptic binding pockets and novel mechanisms of action. Rayca merges computational sophistication with iterative experimental validation. Using proprietary in silico workflows, we optimize molecular properties such as binding affinity, selectivity, and pharmacokinetics, all while minimizing off-target effects. For biologics, our epitope mapping and protein engineering pipelines refine binding interfaces to achieve superior stability and reduced immunogenicity. For small molecules and peptides, we explore chemical libraries at scale, balancing ADMET properties with therapeutic potency. From gene-editing tools to peptidomimetics, every candidate we design is rigorously tested against predictive and experimental benchmarks. Rayca delivers therapies that redefine possibilities in oncology, immunotherapy, and rare diseases.

网站
https://rayca.ai/
所属行业
生物技术研究
规模
11-50 人
总部
San Francisco，CA
类型
私人持股
创立
2022
领域
Computational Biology、AI Drug Design、Drug Discovery、Computational Drug Design、NGS Data Analysis、Multi-Omics、Bioinformatics、AI Drug Discovery、Peptidomimetics、Antibody Drugs、ADCs、CAR T-Cell Therapy、Protein Design、Small Molecule、Rare Diseases、Oncology、Immuno-Oncology和Immunotherapy

地点

  • 主要

    166 Geary St

    US，CA，San Francisco，94108

    获取路线

  • 71-75 Shelton Street

    Covent Garden

    GB，England，London，WC2H 9JQ

    获取路线

Rayca Precision员工

查看全部员工

动态

相似主页

查看职位